These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2209665)

  • 21. Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia.
    Malloy MJ; Kane JP; Kunitake ST; Tun P
    Ann Intern Med; 1987 Nov; 107(5):616-23. PubMed ID: 3662275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia.
    Bruckert E; De Gennes JL; Malbecq W; Baigts F
    Clin Cardiol; 1995 Nov; 18(11):621-9. PubMed ID: 8590530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study.
    Raal FJ; Hovingh GK; Blom D; Santos RD; Harada-Shiba M; Bruckert E; Couture P; Soran H; Watts GF; Kurtz C; Honarpour N; Tang L; Kasichayanula S; Wasserman SM; Stein EA
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):280-290. PubMed ID: 28215937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
    Lee WP; Datta BN; Ong BB; Rees A; Halcox J
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of atherosclerosis in patients with familial hypercholesterolaemia under LDL-apheresis.
    Borberg H; Gaczkowski A; Hombach V; Oette K; Stoffel W
    Prog Clin Biol Res; 1988; 255():317-26. PubMed ID: 3340643
    [No Abstract]   [Full Text] [Related]  

  • 26. Low density lipoprotein apheresis in pediatric patients with homozygous familial hypercholesterolemia.
    Coker M; Ucar SK; Simsek DG; Darcan S; Bak M; Can S
    Ther Apher Dial; 2009 Apr; 13(2):121-8. PubMed ID: 19379151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.
    Raal FJ; Santos RD; Blom DJ; Marais AD; Charng MJ; Cromwell WC; Lachmann RH; Gaudet D; Tan JL; Chasan-Taber S; Tribble DL; Flaim JD; Crooke ST
    Lancet; 2010 Mar; 375(9719):998-1006. PubMed ID: 20227758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypocholesterolaemic effects of lovastatin in familial defective apolipoprotein B-100.
    Illingworth DR; Vakar F; Mahley RW; Weisgraber KH
    Lancet; 1992 Mar; 339(8793):598-600. PubMed ID: 1347103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in plasma low-density lipoprotein cholesterol and urinary mevalonic acid by lovastatin in patients with heterozygous familial hypercholesterolemia.
    Pappu AS; Illingworth DR; Bacon S
    Metabolism; 1989 Jun; 38(6):542-9. PubMed ID: 2725293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma exchange for homozygous familial hypercholesterolaemia: the Cape Town experience.
    Marais AD; Wood L; Firth JC; Hall JM; Jacobs P
    Transfus Sci; 1993 Jul; 14(3):239-47. PubMed ID: 10146335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
    Heath KE; Gudnason V; Humphries SE; Seed M
    Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to drugs and diet in a compound heterozygote for familial hypercholesterolaemia.
    Gudnason V; Muller DP; Lloyd JK; Humphries SE
    Arch Dis Child; 1995 Dec; 73(6):538-40. PubMed ID: 8546515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation for treatment of cardiovascular disease: comparison with medication and plasma exchange in homozygous familial hypercholesterolemia.
    Hoeg JM; Starzl TE; Brewer HB
    Am J Cardiol; 1987 Mar; 59(6):705-7. PubMed ID: 3548303
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study).
    Waldmann E; Vogt A; Crispin A; Altenhofer J; Riks I; Parhofer KG
    Atherosclerosis; 2017 Apr; 259():20-25. PubMed ID: 28279833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.
    Stefanutti C; Blom DJ; Averna MR; Meagher EA; Theron Hd; Marais AD; Hegele RA; Sirtori CR; Shah PK; Gaudet D; Vigna GB; Sachais BS; Di Giacomo S; du Plessis AM; Bloedon LT; Balser J; Rader DJ; Cuchel M;
    Atherosclerosis; 2015 Jun; 240(2):408-14. PubMed ID: 25897792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Homozygous familial hypercholesterolemia. Response to combined cholestyramine and lovastatin therapy].
    Obando Santaella I; Fernández Gómez E; Mongil Ruiz I; Escobar Gallego A; García Alegría JJ; Gascón Luna F; Masana Marín L
    An Esp Pediatr; 1990 Jul; 33(1):58-60. PubMed ID: 2252289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effect of simvastatin in patients with drug resistant familial hypercholesterolaemia.
    Lewis-Barned NJ; Ball MJ
    N Z Med J; 1992 Jul; 105(938):284-6. PubMed ID: 1495661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
    Pappu AS; Illingworth DR
    J Lab Clin Med; 1989 Nov; 114(5):554-62. PubMed ID: 2809398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The long-term therapy of familial hypercholesterolemia with heparin-induced extracorporeal LDL precipitation].
    Roth R; Köster W; Wanner C; Andre M; Orth M; Wieland H; Schollmeyer P
    Dtsch Med Wochenschr; 1992 Jul; 117(30):1135-41. PubMed ID: 1633760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia.
    Græsdal A; Bogsrud MP; Holven KB; Nenseter MS; Narverud I; Langslet G; Brekke M; Retterstøl K; Arnesen KE; Ose L
    J Clin Lipidol; 2012; 6(4):331-9. PubMed ID: 22836070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.